

Dr. Sharon Hausman-Cohen: How to Address Dementia, Autism, and Other Chronic Diseases with Genomic Testing
Feb 21, 2024
Dr. Sharon Hausman-Cohen, Chief Medical Officer at IntellxxDNA, specializes in the intersection of integrative medicine and genomics. In this engaging discussion, she unpacks the powerful role of genomic testing in personalized medicine, especially for conditions like dementia and autism. She explains the difference between genetics and genomics, highlighting how lifestyle can influence gene expression. Through compelling case studies, she reveals how tailored interventions can optimize health outcomes, emphasizing the urgent need for understanding genetic predispositions amid rising chronic disease rates.
AI Snips
Chapters
Transcript
Episode notes
Genetics vs Genomics
- Genomics studies how genes interact and how to modify them, unlike genetics which studies inherited diseases.
- Chronic diseases like diabetes or heart disease aren't caused by single genes, but by the interplay of many.
Polygenic Risk Scores and IntelliX DNA
- Polygenic risk scores consider multiple gene variants but may not offer actionable solutions.
- IntelliX DNA focuses on modifiable genes and their interactions with lifestyle factors.
Dr. Hyman's Dementia Patient
- Dr. Hyman treated a dementia patient with multiple genetic risk factors, including ApoE4 and methylation genes.
- By addressing the patient's heavy metal toxicity, gut health, and metabolic issues, his dementia significantly improved.